Phase II trial of retroperitoneal lymph node dissection as first-line treatment for testicular seminoma with isolated retroperitoneal disease (1-2cm)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Age: Between 16 - 100 Years
Gender: Male or Female
Stage IIA pure seminoma OR stage I pure seminoma with isolated retroperitoneal relapse
Lymphadenopathy in the retroperitoneum
Chest imaging negative for metastasis no more than 6 weeks prior to the date of RPLND
Primary tumor excised by radical inguinal orchiectomy and pathology consistent with pure seminoma with negative surgical margins
Second primary malignancy
History of receiving chemotherapy or radiotherapy
Patients receiving any other investigational agents
Any history of serum AFP elevation
Uncontrolled intercurrent illness
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required